Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

9 Machinery Stocks to Sell Now

The ratings of nine machinery stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Bad Analyst Earnings Revisions — REXX TLM KEG LONG ASYS

This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

4 Chemicals Stocks to Sell Now

For the current week, the overall ratings of four chemicals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks to Sell for March

The market may be at historical highs, but weak technicals and poor seasonality make these names stocks to sell now.

BKS Stock Still Doomed After College Spinoff Plans

Barnes & Noble (BKS) stock is up today after announcing a spinoff of its college bookstore business. I'm afraid it's too little, too late for this company.

GOOG: Why YouTube Doesn’t Matter for Google Stock

The lack of profitability of YouTube comes with important lessons for more than just Google stock investors.

5 Construction and Engineering Stocks to Sell Now

This week, the ratings of five construction and engineering stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

10 Worst “Strong Sell” Stocks This Week — P GTI NRP and more

This week, these ten stocks have the worst year-to-date performance. Each of these also rates an "F" ("strong sell") on Portfolio Grader.

3 Energy Services Stocks to Sell Now

The overall ratings of three energy services stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Bad Earnings Surprises — CRR PKX MGM EFC ROMA

This week, these five stocks have the worst ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

5 Communications Equipment Stocks to Sell Now

For the current week, the overall ratings of five communications equipment stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Life Science Stocks to Sell Now

This week, the overall grades of three life science stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Restaurant and Resort Stocks to Sell Now

The ratings of four restaurant and resort stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Software Stocks to Sell Now

For the current week, the overall ratings of five software stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

A Bar Too High for LendingClub as Growth Story Slows

Lending Club shares are getting punished for dashing its own growth story -- and having a crazy valuation for what is essentially a broker.

Why Is DISH Stock Massively Overvalued?

DISH stock, while rewarding its recent investors, could crush those who pile into it now. Here's why Wall Street is overvaluing the pay-TV provider.

Target Corporation’s Cool Outlook Limits Upside in TGT Stock

Target had a better-than-expected holiday selling season, but a tough backdrop for consumer spending could keep a lid on TGT stock.

6 Semiconductor Stocks to Sell Now

The overall ratings of six semiconductor stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

9 Biotechnology Stocks to Sell Now

For the current week, the overall ratings of nine biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").